WallStreetZenWallStreetZen

NYSE: CANO
Cano Health Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CANO

Based on 4 analysts offering 12 month price targets for Cano Health Inc.
Min Forecast
$1.00-31.51%
Avg Forecast
$1.56+7.05%
Max Forecast
$2.50+71.23%

Should I buy or sell CANO stock?

Based on 4 analysts offering ratings for Cano Health Inc.
Sell
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
2 analysts 50%
Sell
1 analysts 25%
Strong Sell
1 analysts 25%

Be the first to know when Wall Street analysts revise their CANO stock forecasts and price targets.

CANO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Piper Sandler
Top 25%
76
Strong SellMaintains$1.00-31.51%2023-05-16
Credit Suisse
Top 7%
94
HoldReiterates$2.50+71.23%2023-05-12
UBS
Bottom 20%
20
HoldDowngrades$1.25-14.38%2023-01-06
Bank of America
Bottom 38%
38
SellReinstates$1.50+2.74%2022-12-13

1 of 1

Forecast return on equity

Is CANO forecast to generate an efficient return?
Company
N/A
Industry
-0.01%
Market
71.35%

Forecast return on assets

Is CANO forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.01%

CANO revenue growth forecast

How is CANO forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
19.12%
Industry
6.32%
Market
8.43%
CANO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CANO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CANO vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
CANO$1.46$1.56+7.05%Sell
MODV$49.66$102.33+106.07%Strong Buy
BKD$3.54$5.50+55.37%Hold
EHAB$13.28$15.83+19.22%Hold
NHC$61.40N/AN/A
View Top Medical Care Facility Stocks

Cano Health Stock Forecast FAQ

Is Cano Health Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NYSE: CANO) stock is to Sell CANO stock.

Out of 4 analysts, 0 (0%) are recommending CANO as a Strong Buy, 0 (0%) are recommending CANO as a Buy, 2 (50%) are recommending CANO as a Hold, 1 (25%) are recommending CANO as a Sell, and 1 (25%) are recommending CANO as a Strong Sell.

If you're new to stock investing, here's how to buy Cano Health stock.

What is CANO's forecast return on equity (ROE) for 2023-2026?

(NYSE: CANO) forecast ROE is N/A, which is considered weak.

What is CANO's Price Target?

According to 4 Wall Street analysts that have issued a 1 year CANO price target, the average CANO price target is $1.56, with the highest CANO stock price forecast at $2.50 and the lowest CANO stock price forecast at $1.00.

On average, Wall Street analysts predict that Cano Health's share price could reach $1.56 by May 16, 2024. The average Cano Health stock price prediction forecasts a potential upside of 7.05% from the current CANO share price of $1.46.

What is CANO's forecast return on assets (ROA) for 2023-2026?

(NYSE: CANO) forecast ROA is N/A, which is lower than the forecast US Medical Care Facilities industry average of -0.01%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.